Literature DB >> 27869812

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation.

F He1, M R Verneris2, S Cooley1, B R Blazar2, M L MacMillan2, L F Newell3, A Panoskaltsis-Mortari2, T DeFor1, D J Weisdorf1, S G Holtan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27869812      PMCID： PMC5582052          DOI： 10.1038/bmt.2016.261

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Why is epidermal growth factor present in the gut lumen?

Authors:  R J Playford; N A Wright
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

2.  Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

Authors:  Shernan G Holtan; Michael R Verneris; Kirk R Schultz; Laura F Newell; Gabrielle Meyers; Fiona He; Todd E DeFor; Gregory M Vercellotti; Arne Slungaard; Margaret L MacMillan; Sarah A Cooley; Bruce R Blazar; Angela Panoskaltsis-Mortari; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-07       Impact factor: 5.742

3.  Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.

Authors:  M S Kennedy; H J Deeg; R Storb; K Doney; K M Sullivan; R P Witherspoon; F R Appelbaum; P Stewart; J Sanders; C D Buckner
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

4.  Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?

Authors:  Konstantinos A Oikonomou; Andreas N Kapsoritakis; Anastasia I Kapsoritaki; Anastassios C Manolakis; Fotios D Tsiopoulos; Anastassios E Germenis; Spiros P Potamianos
Journal:  Growth Factors       Date:  2010-10-25       Impact factor: 2.511

Review 5.  Epidermal growth factor, epidermal growth factor receptors, intestinal growth, and adaptation.

Authors:  W M Wong; N A Wright
Journal:  JPEN J Parenter Enteral Nutr       Date:  1999 Sep-Oct       Impact factor: 4.016

6.  Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.

Authors:  Y Oka; D N Orth
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 7.  Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa.

Authors:  J W Konturek; T Brzozowski; S J Konturek
Journal:  J Clin Gastroenterol       Date:  1991       Impact factor: 3.062

8.  Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells.

Authors:  J Blay; K D Brown
Journal:  J Cell Physiol       Date:  1985-07       Impact factor: 6.384

9.  High dose bolus methylprednisolone for the treatment of acute graft versus host disease.

Authors:  A Bacigalupo; M T van Lint; F Frassoni; M Podesta'; G Veneziano; G Avanzi; V Vitale; A M Marmont
Journal:  Blut       Date:  1983-03

10.  Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers.

Authors:  Amir Harandi; Aisha S Zaidi; Abigail M Stocker; Damian A Laber
Journal:  J Oncol       Date:  2009-05-06       Impact factor: 4.375
View more
  3 in total

1.  Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.

Authors:  S G Holtan; L F Newell; C Cutler; M R Verneris; T E DeFor; J Wu; A Howard; M L MacMillan; J H Antin; B R Blazar; D J Weisdorf; A Panoskaltsis-Mortari
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

2.  Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

Authors:  Shernan G Holtan; Todd E DeFor; Angela Panoskaltsis-Mortari; Nandita Khera; John E Levine; Mary E D Flowers; Stephanie J Lee; Yoshihiro Inamoto; George L Chen; Sebastian Mayer; Mukta Arora; Jeanne Palmer; Corey S Cutler; Sally Arai; Aleksandr Lazaryan; Laura F Newell; Madan H Jagasia; Iskra Pusic; William A Wood; Anne S Renteria; Gregory Yanik; William J Hogan; Elizabeth Hexner; Francis Ayuk; Ernst Holler; Udomsak Bunworasate; Yvonne A Efebera; James L M Ferrara; Joseph Pidala; Alan Howard; Juan Wu; Javier Bolaños-Meade; Vincent Ho; Amin Alousi; Bruce R Blazar; Daniel J Weisdorf; Margaret L MacMillan
Journal:  Blood Adv       Date:  2018-08-14

Review 3.  Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions.

Authors:  Fiona C He; Shernan G Holtan
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.